Independence Blue Cross Paid $22.5 Million in Settlement
The insurer resolved federal allegations involving inaccurate Medicare diagnosis code submissions.
Updated on Sept. 30, 2026 in Healthcare
Live Poll
Should insurance companies face stricter oversight when reporting medical diagnosis data to federal programs?
Independence Blue Cross agreed to pay $22.5 million to settle False Claims Act allegations regarding the submission of inaccurate diagnosis codes to Medicare. The resolution covers payment years from 2017 through 2021.
Why it matters
The settlement addresses claims that the insurer intentionally sought higher payments by using chart reviews to find additional compensation while ignoring results that indicated Medicare overpayments. These actions allegedly inflated risk adjustment payments to the company.
Independence Blue Cross will pay $22.5 million to resolve the allegations, with a former employee receiving a $3,825,000 whistleblower share. The case involves diagnosis code reporting issues spanning the 2017 to 2021 payment years.
The players
Independence Blue Cross
This is a Pennsylvania-based health insurance provider that provides coverage for millions of members.
CMS
The Centers for Medicare & Medicaid Services is the federal agency that oversees Medicare and monitors insurer compliance.
The details
The United States alleged the company utilized a nurse review program to identify patient medical conditions for payment purposes while failing to withdraw codes that required correction. This practice allowed the firm to retain Medicare overpayments during the five-year period.
Timeline
The allegations involve payment years 2017 through 2021.
The settlement agreement was announced on September 30, 2026.
Market Landscape
This settlement follows the established pattern of federal authorities using the False Claims Act to recover funds from private insurers accused of improper billing practices. Such actions underscore the federal oversight applied to the $530 billion annual market for Medicare Advantage plans.
While this settlement involves federal oversight, it does not immediately change individual insurance premiums or benefits for members. Customers should continue to monitor their annual explanation of benefits statements for accuracy.
The takeaway
The resolution of this case highlights the importance of whistleblower protections in uncovering corporate billing errors. Employees who identify systemic inaccuracies in medical coding remain a primary avenue for federal investigators to track potential Medicare overpayments.
Further reading
For additional context on industry standards, visit the Healthcare section.
More information
To report suspected billing irregularities, visit the HHS health fraud reporting portal.
Live Poll
Should insurance companies face stricter oversight when reporting medical diagnosis data to federal programs?
